Long-term skin damage due to chemical weapon exposure

Cutaneous and Ocular Toxicology

Volumn 30, Issue 1, 2011, Pages 64-68

  Firooz, Alireza ^a   Sadr, Bardia ^a   Davoudi, Seyed M ^b   Nassiri Kashani, Mansour ^a   Panahi, Yunes ^b   Dowlati, Yahya ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

angioma; blister; Mustard; scar; skin cancer

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPRURITIC AGENT; CAPSAICIN; CETIRIZINE; CHEMICAL WARFARE AGENT; CHLORPHENIRAMINE; CORTICOSTEROID; CYPROHEPTADINE; DIPHENHYDRAMINE; EMOLLIENT AGENT; FEXOFENADINE; GLYCEROL; HYDROXYZINE; LANOLIN ALCOHOL; LORATADINE; MENTHOL; MUSTARD GAS; OLIVE OIL; PETROLATUM; PHENOL; PIMECROLIMUS; TACROLIMUS;

ACUTE DISEASE; ARTICLE; BANDAGE; BLISTER; CHRONIC DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRY SKIN; EDEMA; ERYTHEMA; EVENING DOSAGE; HUMAN; HYPERPIGMENTATION; MORNING DOSAGE; PRURITUS; SKIN ATROPHY; SKIN CANCER; SKIN DEFECT; SKIN HEMANGIOMA; SKIN INFLAMMATION; SKIN SCAR; SOLDIER; STRIA; TELANGIECTASIA; XEROSIS;

CHEMICAL WARFARE AGENTS; CHRONIC DISEASE; DERMATOLOGIC AGENTS; HUMANS; MUSTARD GAS; SKIN; SKIN DISEASES;

EID: 79951640422     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.529547     Document Type: Article

References (33)

1. Szinicz L. History of chemical and biological warfare agents. Toxicology 2005;214:167-181. (Pubitemid 41406257)
2. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boca Raton, Fla: CRC Press, 1991.
3. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005;214:198-209. (Pubitemid 41406260)
4. Smith KJ, Hurst CG, Moeller RB, Skelton HG, Sidell FR. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 1995;32:765-776.
5. Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK, Casillas RP, et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010;114:5-19.
6. Emadi SN, Moeineddin F, Sorush MR. Urinary and cutaneous complications of sulphur mustard poisoning preceding pulmonary and ocular involvement: an unusual sequence of symptoms. Clin Exp Dermatol 2009;34: e7-10.
7. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006;99:273-282. (Pubitemid 44578902)
8. Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T. Acute effects of sulfur mustard injury-Munich experiences. Toxicology 2009;263:3-8.
9. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992;128:775-780.
10. Rosenthal DS, Velena A, Chou FP, Schlegel R, Ray R, Benton B, et al. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J Biol Chem 2003;278:8531-8540. (Pubitemid 36800606)
11. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45:1136-1143. (Pubitemid 37420858)
12. Moaiedmohseni S, Ghazanfari T, Araghizadeh H, Soroush MR, Yaraee R, Hassan ZM, et al. Long-term health status 20 years after sulfur mustard exposure. Toxin Rev. 2009;28:3-7.
13. Moin A, Ghazanfari T, Davoudi SM. Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran. Toxin Rev. 2009;28:24-29.
14. Davoudi SM, Keshavarz S, Sadr B, Shohrati M, Naghizadeh MM, Farsinejad K, et al. Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study. J Eur Acad Dermatol Venereol 2009;23:940-944.
15. Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation. Arch Dermatol 2008;144:1059-1061.
16. Lee CH, Chuang HY, Shih CC, Jong SB, Chang CH, Yu HS. Transepidermal water loss, serum IgE and β-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006;154:1100-1107.
17. Davoudi SM, Sadr B, Hayatbakhsh MR, Keshavarz S, Shohrati M, Naghizadeh MM, et al. Comparative study of skin sebum and elasticity level in patients with sulfur mustardinduced dermatitis and healthy controls. Skin Res Technol. 2010 May;16 (2):237-42.
18. Davoudi SM, Keshavarz S, Sadr B, Shohrati M, Naghizadeh MM, Farsinejad KH, et al. Comparison of skin erythema and melanin level in sulfur mustard induced chronic skin lesions and normal skin. Iran J Dermatol 2008;11:151-154.
19. Fekri A, Janghorbani M. Long term efect in chemical veterans in Kerman province. J Kerman Med Sci University 1996;3:108-119.
20. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS. Mustard gas scarring with specific pigmentary, trophic and vascular charactristics (case report, 16-year postexposure). Ecotoxicol Environ Saf 2008;69:574-576. (Pubitemid 351305014)
21. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol 2006;45:1025-1031. (Pubitemid 44317113)
22. Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. J Am Acad Dermatol 1999;40:646-647. (Pubitemid 29153204)
23. Maleki M, Javidi Z, Soofizadeh V Ebrahimzadeh S. Multiple large cherry angiomas after exposure to sulfur mustard gas in Iranian veterans in Iraq-Iran war: A historical cohort study. Iran J Dermatol 2006;9:40-45.
24. Heston WE. Occurrence of tumors in mice injected subcutaneously with sulfur mustard and nitrogen mustard. J Natl Cancer Inst 1953;14:131-140.
25. Inada S, Hiragun K, Seo K, Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan, with special reference to mustard gas exposure. J Dermatol 1978;5:49-60. (Pubitemid 8353847)
26. Klehr NW. Late manifestations in former mustard gas workers with special reference to cutaneous findings. Z Hautkr 1984;59:1161-1164;1167-11670.
27. Hosseini-khalili A, Haines DD, Modirian E, Soroush M, Khateri S, Joshi R, et al. Mustard gas exposure and carcinogenesis of lung. Mutat Res 2009;678:1-6.
28. Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol 2008;47:557-561. (Pubitemid 351676493)
29. Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J 2007;48:392-395. (Pubitemid 351235385)
30. Panahi Y, Davoudi SM, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure. Cutan Ocul Toxicol 2008;27:203-211.
31. Shohrati M, Davoudi M, Almasi M, Sadr B, Peyman M. Comparative study of Unna's Boot and betamethasone cream in the treatment of sulfur mustard-related pruritus. Cutan Ocul Toxicol 2007;26:303-309. (Pubitemid 350208871)
32. Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. Basic Clin Pharmacol Toxicol 2009;104:171-175.
33. Shohrati M, Davoudi SM, Keshavarz S, Sadr B, Tajik A. Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan Ocul Toxicol 2007;26:249-255. (Pubitemid 47237802)